Erectile dysfunction — all decisions

The veteran's appeal requests were not timely filed, and good cause was not shown to accept the late filings.

The Board granted effective dates of May 19, 2022, for the assignment of a 30 percent evaluation for pseudofolliculitis barbae and for the grant of a total disability evaluation based upon individual unemployability due to service-connected disabilities (TDIU), and July 16, 2020, for the grant of service connection for major depressive disorder.

The Board granted service connection for cervical strain, left and right hip disabilities (post-traumatic arthritis), erectile dysfunction, and SMC based on loss of use of a creative organ with an effective date of September 28, 2012. Other claims were denied.

The Board denied the Veteran's appeal for a compensable rating for erectile dysfunction, as the criteria for such a rating were not met.

The Board remands the claim for an addendum opinion to properly address secondary service connection pursuant to Spicer v. McDonough, 61 F.4th 1360 (Fed. Cir. 2023).

The Board remands the claims for service connection and TDIU due to a pre-decisional duty to assist error regarding SSA records.

The Board denied entitlement to a total disability rating based on individual unemployability due to service-connected disability prior to April 28, 2020, and denied earlier effective dates for DEA benefits. The Board granted restoration of a 50 percent disability rating for migraines effective July 1, 2023, but denied ratings in excess of the assigned levels for other conditions.

The Board remands the claims for service connection for chronic kidney disease, hypertension, supraventricular arrhythmias, erectile dysfunction and coronary artery disease to correct a pre-decisional duty to assist error.

The Board denied service connection for bilateral hearing loss, and remanded the claims for erectile dysfunction and obstructive sleep apnea.

The Board granted service connection for bilateral pes planus and plantar fasciitis, an initial rating of 50 percent for migraine headaches, but denied service connection for obstructive sleep apnea (OSA), traumatic brain injury (TBI), a compensable rating for erectile dysfunction, and a higher rating for posttraumatic stress disorder (PTSD).

The Board denied service connection for left and right shoulder disabilities, multi-joint arthritis, and erectile dysfunction as the evidence did not support a finding that these conditions were related to the Veteran's service.

The Board granted a rating of 20 percent, but no higher, for erectile dysfunction and remanded the claim for a rating in excess of 20 percent for slight lumbar scoliosis with IVDS.

The Board remands the claim for service connection for erectile dysfunction with hypogonadism to the AOJ for an adequate medical examination and opinions.

The Board granted service connection for erectile dysfunction, secondary to the Veteran's service-connected sarcoidosis.

The Board granted service connection for tension headaches, obstructive sleep apnea, and erectile dysfunction, with an initial rating of 50 percent for the tension headaches.

The Board granted an effective date of April 26, 2018, for the award of service connection for multiple sclerosis and associated conditions, chronic migraine headaches, and trigeminal neuralgia.

The Board denied an initial rating in excess of 20 percent for type 2 diabetes mellitus with erectile dysfunction and diabetic retinopathy, as the evidence did not support that the Veteran's medical management required regulation of activities.

The Board remands the claims for service connection and an initial compensable disability rating due to a pre-decisional duty to assist error, including the need for VA examinations.

The Board denied an earlier effective date for the award of service connection for erectile dysfunction and special monthly compensation (SMC) due to a lack of evidence supporting an earlier claim or entitlement.

The Board remands the claims for service connection for asthma, erectile dysfunction, and chronic fatigue syndrome as further development is needed.